Detalhe da pesquisa
1.
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
Breast Cancer Res Treat
; 181(2): 391-401, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323103
2.
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Ann Oncol
; 27(7): 1241-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27029708